Lataa...
Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease
The gut microbiome and intestinal dysfunction have emerged as potential contributors to the development of cardiovascular disease (CVD). Alterations in gut microbiome are well documented in hypertension, atherosclerosis, and heart failure and have been investigated as a therapeutic target. However,...
Tallennettuna:
| Julkaisussa: | Am J Physiol Heart Circ Physiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Physiological Society
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792706/ https://ncbi.nlm.nih.gov/pubmed/32986965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00612.2020 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|